Cargando…
The Safety of an Adjuvanted Autologous Cancer Vaccine Platform in Canine Cancer Patients
Canine cancer rates are similar to humans, though the therapeutic options might be limited. Inducing a patient’s own immune system to have an anti-tumor response is an attractive approach to cancer therapy. In this safety study, autologous tumor vaccines produced specifically for each canine patient...
Autores principales: | Weir, Chris, Oksa, Annika, Millar, Jennifer, Alexander, Miles, Kynoch, Nicola, Walton-Weitz, Zoe, Mackenzie-Wood, Peter, Tam, Felicia, Richards, Hope, Naylor, Richard, Cheng, Katrina, Bennett, Peter, Petrovsky, Nikolai, Allavena, Rachel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313922/ https://www.ncbi.nlm.nih.gov/pubmed/30322015 http://dx.doi.org/10.3390/vetsci5040087 |
Ejemplares similares
-
Cytokine Expression in Canine Lymphoma, Osteosarcoma, Mammary Gland Tumour and Melanoma: Comparative Aspects
por: Irac, Sergio Erdal, et al.
Publicado: (2019) -
Evaluation of an autologous cancer vaccine for the treatment of metastatic canine hemangiosarcoma: a preliminary study
por: Lucroy, Michael D., et al.
Publicado: (2020) -
Advax™, a novel microcrystalline polysaccharide particle engineered from delta inulin, provides robust adjuvant potency together with tolerability and safety
por: Petrovsky, Nikolai, et al.
Publicado: (2015) -
Autologous platelet-rich fibrin stimulates canine periodontal regeneration
por: Kornsuthisopon, Chatvadee, et al.
Publicado: (2020) -
A canine model of aortic arch aneurysm created with autologous pericardium
por: Li, Weixiao, et al.
Publicado: (2022)